Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,000
Closed -$376K 452
2022
Q4
$376K Hold
10,000
0.01% 339
2022
Q3
$375K Hold
10,000
0.01% 316
2022
Q2
$361K Hold
10,000
0.01% 330
2022
Q1
$490K Sell
10,000
-2,500
-20% -$127K 0.02% 302
2021
Q4
$598K Hold
12,500
0.02% 264
2021
Q3
$549K Hold
12,500
0.02% 256
2021
Q2
$549K Hold
12,500
0.02% 257
2021
Q1
$572K Buy
+12,500
New +$524K 0.02% 239

Other funds holding SNV

Glenview Trust's SNV Position: Q1 2023 in Review

Glenview Trust sold out of Synovus (SNV) in Q1 2023, closing a stake of 10,000 shares — an estimated $376K sold.

Glenview Trust first reported a position in SNV in Q1 2021 and held it in 8 quarters. The position peaked at $598K in Q4 2021. 377 funds tracked by Wall St. Rank hold SNV as of Q1 2023.

  • Glenview Trust reported no remaining Synovus position as of Q1 2023 after selling out during the quarter.
  • Glenview Trust sold 10,000 Synovus shares in Q1 2023, an estimated $376K.
  • Glenview Trust first reported a position in Synovus in Q1 2021 and held it in 8 quarters.
  • Glenview Trust's Synovus position peaked at $598K in Q4 2021.
  • 377 funds tracked by Wall St. Rank held Synovus as of Q1 2023.

Based on Glenview Trust's 13F filing for Q1 2023, filed 9 May 2023.